Testing effectiveness (Phase 2)UnknownNCT04952493What this trial is testingAnlotinib or Penpulimab in Combination With RAI for DTCWho this might be right forThyroid Cancer Peking Union Medical College Hospital 42
Not applicableEnded earlyNCT03986593What this trial is testingCryoablation of Bone Metastases From Endocrine TumorsWho this might be right forNeoplasm MetastasisThyroid NeoplasmPheochromocytoma+3 more Instituto do Cancer do Estado de São Paulo 17
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Testing effectiveness (Phase 2)Study completedNCT00886132What this trial is testingSunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsWho this might be right forAdenoid Cystic CarcinomaSalivary Gland Cancer University Health Network, Toronto 14
Testing effectiveness (Phase 2)UnknownNCT04586088What this trial is testingApatinib and Camrelizumab in Recurrent or Metastatic Nasopharyngeal Carcinoma With First-line Treatment FailureWho this might be right forNasopharyngeal CarcinomaRecurrent Nasopharyngeal CarcinomaMetastatic Nasopharyngeal Carcinoma+3 more Sun Yat-sen University 58
Testing effectiveness (Phase 2)Study completedNCT04811027What this trial is testingCombination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCCWho this might be right forHNSCC Immutep S.A.S. 171
Testing effectiveness (Phase 2)UnknownNCT03927495What this trial is testingKN046 in Patients With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Shanghai Chest Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05054439What this trial is testingA Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCCWho this might be right forHead and Neck Squamous Cell Carcinoma Sichuan Baili Pharmaceutical Co., Ltd. 45
Testing effectiveness (Phase 2)UnknownNCT05981157What this trial is testingAnrotinib and Tirelizumab in First-line Treatment of RM-NPCWho this might be right forNasopharyngeal Carcinoma Zhongshan People's Hospital, Guangdong, China 27
Very early researchUnknownNCT04674488What this trial is testingTILs for Treatment of Metastatic or Recurrent Cervical CancerWho this might be right forTILs, Metastatic or Recurrent Cervical Cancer Shanghai OriginCell Therapeutics Co., Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT00020761What this trial is testingIrinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or StomachWho this might be right forEsophageal CancerGastric Cancer Jonsson Comprehensive Cancer Center 51
Testing effectiveness (Phase 2)Looking for participantsNCT07668154What this trial is testingA Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC ParticipantsWho this might be right forHNSCC Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 120
Not applicableStudy completedNCT01858805What this trial is testingCirculating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal CancerWho this might be right forResectable Esophageal Cancer Universitätsklinikum Hamburg-Eppendorf 123
Testing effectiveness (Phase 2)UnknownNCT05659186What this trial is testingPD-1 Inhibitor and Anlotinib Combined With Multimodal Radiotherapy in Recurrent or Metastatic Anaplastic Thyroid CancerWho this might be right forThyroid Cancer West China Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04955886What this trial is testingSurufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Fujian Cancer Hospital 14
Large-scale testing (Phase 3)Study completedNCT03556839What this trial is testingPlatinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab in Metastatic Carcinoma of the CervixWho this might be right forCarcinoma of the Cervix, Stage IVB Grupo Español de Investigación en Cáncer de Ovario 410
Testing effectiveness (Phase 2)Study completedNCT00215995What this trial is testingCisplatin and Irinotecan Chemotherapy, Followed by ZD 1839 (Iressa) in Patients With Esophageal or Gastric CarcinomasWho this might be right forEsophageal CancerGastric Cancer H. Lee Moffitt Cancer Center and Research Institute 21
Early research (Phase 1)Looking for participantsNCT07114601What this trial is testingLY4257496 in Participants With Cancer (OMNIRAY)Who this might be right forBreast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more Eli Lilly and Company 421
Not applicableStudy completedNCT00899821What this trial is testingMicrosphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck CancerWho this might be right forHead and Neck Cancer NYU Langone Health
Early research (Phase 1)Temporarily pausedNCT05958199What this trial is testingNPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7Who this might be right forMetastatic Malignant Neoplasm NextPoint Therapeutics, Inc. 131